Ensign Peak Advisors
FLACU

Ensign Peak Advisors’s Frazier Lifesciences Acquisition Corporation Unit FLACU Stock Holding History

Ensign Peak Advisors’s Portfolio FLACU Stock Details FLACU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-450,000
Closed -$4.44M – 2266
2021
Q3 		$4.44M Hold
450,000
– – 0.01% 705
2021
Q2 		$4.54M Hold
450,000
– – 0.01% 690
2021
Q1 		$4.59M Hold
450,000
– – 0.01% 659
2020
Q4 		$4.68M Buy
+450,000
New +$4.7M 0.01% 630

Other funds holding FLACU

FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.04B AUM 31.03% 1-Year Est. Return
CIM
Cowen Investment Management New York $12M AUM 1.47% 1-Year Est. Return

Ensign Peak Advisors's FLACU Position: Q4 2021 in Review

Ensign Peak Advisors sold out of Frazier Lifesciences Acquisition Corporation Unit (FLACU) in Q4 2021, closing a stake of 450,000 shares — an estimated $4.44M sold.

Ensign Peak Advisors first reported a position in FLACU in Q4 2020 and held it in 4 quarters. The position peaked at $4.68M in Q4 2020. 23 funds tracked by Wall St. Rank hold FLACU as of Q4 2021.

  • Ensign Peak Advisors reported no remaining Frazier Lifesciences Acquisition Corporation Unit position as of Q4 2021 after selling out during the quarter.
  • Ensign Peak Advisors sold 450,000 Frazier Lifesciences Acquisition Corporation Unit shares in Q4 2021, an estimated $4.44M.
  • Ensign Peak Advisors first reported a position in Frazier Lifesciences Acquisition Corporation Unit in Q4 2020 and held it in 4 quarters.
  • Ensign Peak Advisors's Frazier Lifesciences Acquisition Corporation Unit position peaked at $4.68M in Q4 2020.
  • 23 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Unit as of Q4 2021.

Based on Ensign Peak Advisors's 13F filing for Q4 2021, filed 11 Feb 2022.